SIMILAR PATTERNS OF AMINO ACIDS FOR 3CE6_B_ADNB500_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a0i | DNA LIGASE (Escherichiavirus T7) |
PF01068(DNA_ligase_A_M) | 5 | GLU A 194LEU A 207LEU A 219GLY A 218HIS A 216 | None | 1.31A | 3ce6B-1a0iA:undetectable | 3ce6B-1a0iA:20.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a9x | CARBAMOYL PHOSPHATESYNTHETASE (SMALLCHAIN) (Escherichiacoli) |
PF00117(GATase)PF00988(CPSase_sm_chain) | 5 | HIS B1829ASP B1799GLU B1801LEU B1866HIS B1841 | None | 1.08A | 3ce6B-1a9xB:3.7 | 3ce6B-1a9xB:24.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1aua | PHOSPHATIDYLINOSITOLTRANSFER PROTEINSEC14P (Saccharomycescerevisiae) |
PF00650(CRAL_TRIO)PF03765(CRAL_TRIO_N) | 5 | THR A 25ASP A 20LYS A 116ASP A 117LEU A 22 | None | 1.25A | 3ce6B-1auaA:undetectable | 3ce6B-1auaA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eqw | CU,ZN SUPEROXIDEDISMUTASE (Salmonellaenterica) |
PF00080(Sod_Cu) | 5 | HIS A 78ASP A 81LEU A 135GLY A 60HIS A 46 | ZN A 501 (-3.0A) ZN A 501 (-2.4A)NoneNone CU A 502 (-3.2A) | 1.20A | 3ce6B-1eqwA:undetectable | 3ce6B-1eqwA:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eso | CU, ZN SUPEROXIDEDISMUTASE (Escherichiacoli) |
PF00080(Sod_Cu) | 5 | HIS A 78ASP A 81LEU A 135GLY A 60HIS A 46 | ZN A 149 ( 3.0A) ZN A 149 ( 2.4A)NoneNone CU A 150 ( 3.3A) | 1.24A | 3ce6B-1esoA:undetectable | 3ce6B-1esoA:16.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rvk | ISOMERASE/LACTONIZING ENZYME (Agrobacteriumfabrum) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | HIS A 171ASP A 206GLU A 232LEU A 332GLY A 331 | None MG A 999 (-2.7A) MG A 999 (-3.1A)NoneNone | 1.23A | 3ce6B-1rvkA:undetectable | 3ce6B-1rvkA:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tkk | SIMILAR TOCHLOROMUCONATECYCLOISOMERASE (Bacillussubtilis) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ASP A 244GLU A 219LYS A 160LEU A 23GLY A 195 | MG A1601 ( 3.2A) MG A1601 (-2.9A)GLU A2471 (-2.6A)NoneNone | 1.39A | 3ce6B-1tkkA:undetectable | 3ce6B-1tkkA:24.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 134GLU A 200LYS A 230ASP A 234LEU A 392HIS A 398 | ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.5A) | 1.30A | 3ce6B-1v8bA:58.1 | 3ce6B-1v8bA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 54THR A 56ASP A 134GLU A 200LYS A 230ASP A 234LEU A 389LEU A 392GLY A 397HIS A 398MET A 403PHE A 407 | ADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.67A | 3ce6B-1v8bA:58.1 | 3ce6B-1v8bA:54.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2aps | PROTEIN (CU,ZNSUPEROXIDEDISMUTASE) (Actinobacilluspleuropneumoniae) |
PF00080(Sod_Cu) | 5 | HIS A 103ASP A 106LEU A 154GLY A 84HIS A 62 | ZN A 400 ( 3.2A) ZN A 400 (-2.2A)NoneNone CU A 402 ( 3.4A) | 1.19A | 3ce6B-2apsA:undetectable | 3ce6B-2apsA:16.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cn3 | BETA-1,4-XYLOGLUCANHYDROLASE (Ruminiclostridiumthermocellum) |
PF02012(BNR) | 5 | HIS A 275THR A 287ASP A 414GLU A 416GLY A 276 | NoneNone CA A1778 (-2.2A) CA A1778 (-3.2A)None | 1.30A | 3ce6B-2cn3A:undetectable | 3ce6B-2cn3A:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2huo | INOSITOL OXYGENASE (Mus musculus) |
PF05153(MIOX) | 5 | ASP A 88LYS A 127ASP A 124LEU A 254HIS A 123 | INS A 303 (-3.7A)INS A 303 (-2.6A) FE A 302 ( 2.5A)None FE A 301 ( 3.2A) | 1.45A | 3ce6B-2huoA:undetectable | 3ce6B-2huoA:19.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pqd | 3-PHOSPHOSHIKIMATE1-CARBOXYVINYLTRANSFERASE (Agrobacteriumsp.) |
PF00275(EPSP_synthase) | 5 | THR A 275ASP A 300GLU A 299LYS A 205ASP A 201 | None | 1.20A | 3ce6B-2pqdA:undetectable | 3ce6B-2pqdA:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rad | SUCCINOGLYCANBIOSYNTHESIS PROTEIN (Bacillus cereus) |
PF05139(Erythro_esteras) | 5 | THR A 409GLU A 113LEU A 316GLY A 407PHE A 141 | None | 1.47A | 3ce6B-2radA:undetectable | 3ce6B-2radA:22.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vun | ENAMIDASE (Eubacteriumbarkeri) |
PF01979(Amidohydro_1) | 5 | THR A 315ASP A 332GLU A 330LEU A 64HIS A 136 | None | 1.50A | 3ce6B-2vunA:2.2 | 3ce6B-2vunA:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wab | ENDOGLUCANASE E (Ruminiclostridiumthermocellum) |
PF00657(Lipase_GDSL) | 5 | HIS A 316THR A 315GLY A 306HIS A 310MET A 263 | NoneGOL A1341 (-3.7A)NoneBGC A1338 (-4.0A)BGC A1337 (-4.5A) | 1.30A | 3ce6B-2wabA:5.8 | 3ce6B-2wabA:22.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2weu | TRYPTOPHAN5-HALOGENASE (Streptomycesrugosporus) |
PF04820(Trp_halogenase) | 5 | HIS A 54GLU A 366LYS A 370LEU A 152GLY A 153 | None | 1.43A | 3ce6B-2weuA:undetectable | 3ce6B-2weuA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xsr | CATECHOL 1,2DIOXYGENASE (Acinetobacterradioresistens) |
PF00775(Dioxygenase_C)PF04444(Dioxygenase_N) | 5 | ASP A 246LEU A 207GLY A 214HIS A 213PHE A 250 | None | 1.29A | 3ce6B-2xsrA:undetectable | 3ce6B-2xsrA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3azq | AMINOPEPTIDASE (Streptomycesmorookaense) |
PF00326(Peptidase_S9) | 5 | THR A 531ASP A 445LEU A 533GLY A 509PHE A 449 | None | 1.35A | 3ce6B-3azqA:3.6 | 3ce6B-3azqA:22.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b1r | RIBOKINASE, PUTATIVE (Burkholderiathailandensis) |
PF00294(PfkB) | 5 | THR A 271ASP A 300LEU A 60GLY A 262HIS A 265 | None | 1.09A | 3ce6B-3b1rA:4.6 | 3ce6B-3b1rA:22.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e0f | PUTATIVEMETAL-DEPENDENTPHOSPHOESTERASE (Bifidobacteriumadolescentis) |
PF02811(PHP) | 5 | ASP A 15ASP A 260LEU A 32GLY A 263HIS A 262 | None FE A 303 ( 2.6A)NoneNone ZN A 301 ( 3.5A) | 1.45A | 3ce6B-3e0fA:undetectable | 3ce6B-3e0fA:21.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | HIS A 52THR A 54ASP A 130GLU A 155LEU A 343LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 (-3.8A)NAD A 439 ( 4.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.70A | 3ce6B-3g1uA:54.0 | 3ce6B-3g1uA:54.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.39A | 3ce6B-3glqA:59.2 | 3ce6B-3glqA:57.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.50A | 3ce6B-3glqA:59.2 | 3ce6B-3glqA:57.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3goh | ALCOHOLDEHYDROGENASE,ZINC-CONTAINING (Shewanellaoneidensis) |
PF08240(ADH_N) | 5 | ASP A 64LEU A 128LEU A 250GLY A 251HIS A 254 | NoneNoneGOL A 316 (-4.7A)GOL A 316 (-2.9A)None | 1.47A | 3ce6B-3gohA:5.2 | 3ce6B-3gohA:21.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 130GLU A 155LYS A 185ASP A 189LEU A 346 | NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)ADN A 439 ( 4.7A) | 1.14A | 3ce6B-3h9uA:55.9 | 3ce6B-3h9uA:56.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 52THR A 54ASP A 130GLU A 155LYS A 185ASP A 189LEU A 343LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NAD A 438 (-4.0A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.58A | 3ce6B-3h9uA:55.9 | 3ce6B-3h9uA:56.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 132GLU A 192LYS A 222ASP A 226LEU A 381 | ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A) | 1.14A | 3ce6B-3n58A:59.1 | 3ce6B-3n58A:60.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 132LYS A 222ASP A 226LEU A 378HIS A 387 | ADN A 500 (-3.3A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 (-3.4A) | 1.34A | 3ce6B-3n58A:59.1 | 3ce6B-3n58A:60.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 55THR A 57ASP A 132GLU A 192LYS A 222ASP A 226LEU A 378LEU A 381GLY A 386HIS A 387MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.52A | 3ce6B-3n58A:59.1 | 3ce6B-3n58A:60.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ngx | BIFUNCTIONAL PROTEINFOLD (Thermoplasmaacidophilum) |
PF00763(THF_DHG_CYH)PF02882(THF_DHG_CYH_C) | 5 | GLU A 91ASP A 114LEU A 262LEU A 30GLY A 87 | None | 1.40A | 3ce6B-3ngxA:7.9 | 3ce6B-3ngxA:19.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o98 | BIFUNCTIONALGLUTATHIONYLSPERMIDINESYNTHETASE/AMIDASE (Escherichiacoli) |
PF03738(GSP_synth)PF05257(CHAP) | 5 | THR A 446ASP A 387GLU A 392LEU A 416LEU A 475 | None | 1.38A | 3ce6B-3o98A:undetectable | 3ce6B-3o98A:23.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 139GLU A 205LYS A 235ASP A 239LEU A 398HIS A 404 | NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 (-3.4A) | 1.36A | 3ce6B-3oneA:58.6 | 3ce6B-3oneA:59.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64ASP A 139GLU A 205LYS A 235ASP A 239LEU A 395LEU A 398GLY A 403HIS A 404MET A 409PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NAD A 501 (-4.2A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.58A | 3ce6B-3oneA:58.6 | 3ce6B-3oneA:59.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139ASP A 239HIS A 404 | ADE A 506 (-4.6A)ADE A 506 (-4.5A)NoneNAD A 501 ( 4.5A)ADE A 506 (-3.4A) | 1.24A | 3ce6B-3oneA:58.6 | 3ce6B-3oneA:59.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | THR A 67ASP A 139ASP A 239LEU A 398HIS A 404 | ADE A 506 (-4.5A)NoneNAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 (-3.4A) | 1.38A | 3ce6B-3oneA:58.6 | 3ce6B-3oneA:59.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p54 | ENVELOPEGLYCOPROTEIN (Japaneseencephalitisvirus) |
PF00869(Flavi_glycoprot)PF02832(Flavi_glycop_C) | 5 | ASP A 42LEU A 371GLY A 145HIS A 144PHE A 1 | None | 1.32A | 3ce6B-3p54A:undetectable | 3ce6B-3p54A:23.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rre | PUTATIVEUNCHARACTERIZEDPROTEIN (Thermotogamaritima) |
PF01256(Carb_kinase)PF03853(YjeF_N) | 5 | THR A 171ASP A 55ASP A 5GLY A 173HIS A 198 | NoneGOL A 496 (-3.1A)GOL A 496 (-2.9A)NoneNone | 1.43A | 3ce6B-3rreA:5.7 | 3ce6B-3rreA:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ksi | LEUCINEAMINOPEPTIDASE 1,CHLOROPLASTIC (Solanumlycopersicum) |
PF00883(Peptidase_M17)PF02789(Peptidase_M17_N) | 5 | THR A 433ASP A 367LYS A 354ASP A 427LEU A 455 | None MG A 602 (-2.4A) MG A 601 ( 3.8A) MG A 601 ( 3.0A)SO4 A 603 (-3.7A) | 1.30A | 3ce6B-4ksiA:undetectable | 3ce6B-4ksiA:23.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 135GLU A 197LYS A 227ASP A 231LEU A 386 | ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A) | 1.09A | 3ce6B-4lvcA:59.7 | 3ce6B-4lvcA:58.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60ASP A 135GLU A 197LYS A 227ASP A 231LEU A 383LEU A 386GLY A 391HIS A 392MET A 397PHE A 401 | ADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.5A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.62A | 3ce6B-4lvcA:59.7 | 3ce6B-4lvcA:58.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 135ASP A 231HIS A 392 | ADN A 501 (-4.0A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-3.1A)ADN A 501 (-3.5A) | 1.27A | 3ce6B-4lvcA:59.7 | 3ce6B-4lvcA:58.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mz0 | CURL (Mooreaproducens) |
PF00109(ketoacyl-synt)PF00698(Acyl_transf_1)PF02801(Ketoacyl-synt_C)PF16197(KAsynt_C_assoc) | 5 | THR A 495ASP A 914LEU A 895LEU A 493GLY A 899 | None | 1.32A | 3ce6B-4mz0A:undetectable | 3ce6B-4mz0A:19.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hhl | RETRON-TYPE REVERSETRANSCRIPTASE ([Eubacterium]rectale) |
PF00078(RVT_1) | 5 | ASP A 227GLU A 186LEU A 270GLY A 276HIS A 291 | K A 301 (-3.7A)NoneNoneNoneNone | 1.17A | 3ce6B-5hhlA:undetectable | 3ce6B-5hhlA:22.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jiu | RAN-BINDING PROTEIN9 (Homo sapiens) |
PF00622(SPRY) | 5 | HIS A 255ASP A 258LEU A 244GLY A 317PHE A 275 | None | 1.44A | 3ce6B-5jiuA:undetectable | 3ce6B-5jiuA:21.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 137GLU A 211LYS A 241ASP A 245LEU A 404 | SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)SAH A 502 ( 4.7A) | 1.12A | 3ce6B-5utuA:53.7 | 3ce6B-5utuA:49.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 53THR A 55ASP A 137GLU A 211LYS A 241ASP A 245LEU A 401LEU A 404GLY A 409HIS A 410MET A 415PHE A 419 | SAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.66A | 3ce6B-5utuA:53.7 | 3ce6B-5utuA:49.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 53THR A 58ASP A 137ASP A 245HIS A 410 | SAH A 502 (-4.0A)SAH A 502 (-4.2A)SAH A 502 (-3.4A)SAH A 502 (-2.8A)SAH A 502 ( 3.5A) | 1.26A | 3ce6B-5utuA:53.7 | 3ce6B-5utuA:49.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uz5 | PRE-MRNA-PROCESSINGFACTOR 39U1 SMALL NUCLEARRIBONUCLEOPROTEINCOMPONENT PRP42 (Saccharomycescerevisiae) |
no annotation | 5 | THR D 396LEU D 444LEU D 415GLY D 414HIS E 519 | None | 1.33A | 3ce6B-5uz5D:undetectable | 3ce6B-5uz5D:19.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 136GLU A 197LYS A 227ASP A 231LEU A 389 | ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 4.7A) | 1.14A | 3ce6B-5v96A:58.8 | 3ce6B-5v96A:58.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 59THR A 61ASP A 136GLU A 197LYS A 227ASP A 231LEU A 386LEU A 389GLY A 394HIS A 395MET A 400PHE A 404 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.63A | 3ce6B-5v96A:58.8 | 3ce6B-5v96A:58.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 59THR A 64ASP A 136ASP A 231HIS A 395 | ADN A 502 ( 3.9A)ADN A 502 (-4.4A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 3.4A) | 1.20A | 3ce6B-5v96A:58.8 | 3ce6B-5v96A:58.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55THR A 57ASP A 131GLU A 156LYS A 186MET A 358PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNone9W4 A 502 (-3.6A)None | 0.81A | 3ce6B-5w4bA:40.7 | 3ce6B-5w4bA:55.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55THR A 57ASP A 131LYS A 186ASP A 190MET A 358PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 0.74A | 3ce6B-5w4bA:40.7 | 3ce6B-5w4bA:55.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190GLY A 352HIS A 353MET A 358PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.97A | 3ce6B-5w4bA:40.7 | 3ce6B-5w4bA:55.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LYS A 186ASP A 190LEU A 344LEU A 347GLY A 352HIS A 353MET A 358 | NoneNAD A 501 (-4.1A)NAD A 501 (-4.0A)9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A) | 1.08A | 3ce6B-5w4bA:40.7 | 3ce6B-5w4bA:55.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | THR A 57ASP A 131LYS A 186ASP A 190HIS A 353MET A 358PHE A 362 | 9W4 A 502 (-2.9A)NoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.98A | 3ce6B-5w4bA:40.7 | 3ce6B-5w4bA:55.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60ASP A 136GLU A 161LYS A 191ASP A 195LEU A 349LEU A 352GLY A 357HIS A 358MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.19A | 3ce6B-6aphA:56.3 | 3ce6B-6aphA:54.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 136ASP A 195HIS A 358 | ADN A 501 (-3.9A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 ( 3.5A) | 1.20A | 3ce6B-6aphA:56.3 | 3ce6B-6aphA:54.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | THR A 63ASP A 136ASP A 195LEU A 352HIS A 358 | ADN A 501 (-4.5A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A)ADN A 501 ( 3.5A) | 1.37A | 3ce6B-6aphA:56.3 | 3ce6B-6aphA:54.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6b5f | NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE (Yersiniaenterocolitica) |
no annotation | 5 | THR A 246ASP A 229LEU A 4LEU A 151PHE A 189 | None | 1.46A | 3ce6B-6b5fA:2.6 | 3ce6B-6b5fA:23.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 6 | ASP B 139GLU B 164LYS B 194ASP B 198LEU B 376HIS B 382 | ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)ADN B 502 ( 4.8A)ADN B 502 (-3.4A) | 1.40A | 3ce6B-6f3mB:52.2 | 3ce6B-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 12 | HIS B 61THR B 63ASP B 139GLU B 164LYS B 194ASP B 198LEU B 373LEU B 376GLY B 381HIS B 382MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)NAD B 501 ( 3.9A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.4A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.62A | 3ce6B-6f3mB:52.2 | 3ce6B-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | HIS B 61THR B 66ASP B 139ASP B 198HIS B 382 | ADN B 502 ( 4.0A)ADN B 502 (-4.6A) ZN B 505 ( 2.5A)ADN B 502 (-2.7A)ADN B 502 (-3.4A) | 1.20A | 3ce6B-6f3mB:52.2 | 3ce6B-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | THR B 66ASP B 139ASP B 198LEU B 376HIS B 382 | ADN B 502 (-4.6A) ZN B 505 ( 2.5A)ADN B 502 (-2.7A)ADN B 502 ( 4.8A)ADN B 502 (-3.4A) | 1.40A | 3ce6B-6f3mB:52.2 | 3ce6B-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | ASP A 134GLU A 159LYS A 189ASP A 193LEU A 350HIS A 356 | ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A)ADN A 501 (-3.4A) | 1.37A | 3ce6B-6gbnA:55.6 | 3ce6B-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 12 | HIS A 56THR A 58ASP A 134GLU A 159LYS A 189ASP A 193LEU A 347LEU A 350GLY A 355HIS A 356MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)NAD A 502 (-3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.4A)ADN A 501 (-3.6A)None | 0.64A | 3ce6B-6gbnA:55.6 | 3ce6B-6gbnA:undetectable |